ClearTalk: Communications Tech Beyond the Pandemic

 

On this episode of ClearTalk, host Tyler Kern was joined by CTSI President and CEO Gino Ruta, and Vice President Ron Pusey, to discuss how the COVID-19 pandemic highlights a need for rapid deployment of communications technology that extends well beyond the confines of this period of uncertainty.

CTSI is a mission-critical communications service provider, making the company uniquely qualified to help assess the lasting impact of this pandemic and the need for communication solutions in industries like government, healthcare, education, corporate, houses of worship, and other verticals.

Rapid deployment is key in these industries. To highlight the concept of rapid deployment as it relates to critical communications technology, Pusey outlined a recent situation that came about as a result of the novel coronavirus.

“Obviously, this crisis has required a lot of folks to have to respond quickly to their clients’ needs,” he said. “We do a fair amount of business with VCU Health Systems, and they had a critical need to convert 180 of their honor residences back into hospital-ready rooms for their lower-acuity cases. … They called us on a Wednesday, said they needed 72 rooms up the following Monday and another 108 the following Friday. So, we had roughly 10 days to convert 180 rooms.

“We were able to do that through the depth of our resources.”

This kind of rapid deployment has been thrust into the spotlight due to the pressures of the collective response to COVID-19, but, moving forward, it will be even more critical to ensure the world’s industries are prepped not only for the resumption of normal operation, but future disruption.

Still, there’s a balance to be struck between agility and the standards of quality CTSI adheres to, and Ruta said the company is always ready to walk that line.

“What we can do is build on what we’re doing each day to be prepared for rapid deployment,” he said. “And we do that with standards. It can be something as simple as standard drawings for all the technologies that we deploy, standard cables, standard connections … Whenever something comes out and needs to be done very quickly, we’re just accelerating the time frame.”

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More